Sussex Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
      • 1.1 Chronic bowel disorders
      • 1.2 Constipation and bowel cleansing
      • 1.3 Antisecretory drugs and mucosal protectants
      • 1.4 Exocrine pancreatic insufficiency
      • 1.5 Food allergy
      • 1.6 Gastric acid disorders and ulceration
      • 1.7 Gastro-intestinal smooth muscle spasm
      • 1.8 Liver disorders and related conditions
      • 1.9 Obesity
      • 1.10 Rectal and anal disorders
      • 1.11 Stoma care
      • 1.12 Other Gastro-intestinal system items
      • 1.13 Bile acid sequestrants
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Shortage of Pancreatic enzyme replacement therapy (PERT) NHS Sussex response

 

Pancreatin

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Creon 10000 gastro-resistant capsules

Pack
100 capsule
60 capsule

Creon 25000 gastro-resistant capsules

Pack
100 capsule
60 capsule
50 capsule

Creon Micro Pancreatin 60.12mg gastro-resistant granules

Pack
20 gram

Nutrizym 22 gastro-resistant capsules

Pack
100 capsule

Pancrex V capsules

Pack
300 capsule

Pancrex V 125mg capsules

Pack
300 capsule

Pancrex V oral powder

Pack
300 gram

Pancreatin (Import)

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Pancreaze 10500 Capsules

Pancreaze 21000 Capsules

Zenpep 10000 Capsules

Zenpep 25000 Capsules

Creon 10000 Capsules

Creon 25000 Capsules

Pangrol 10,000 capsules

Pack
200 capsule

Pangrol 25,000 capsules

Pack
200 capsule

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2025